Combination of disulfiram and Copper-Cysteamine nanoparticles induces mitochondria damage and promotes apoptosis in endometrial cancer.
Journal Information
Journal Title: Bioact Mater
Detailed journal information not available.
Publication Details
Subject Category: Materials Science, Biomaterials
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of competing interest The authors declare no conflict of interest."
"This work was supported by the 10.13039/501100001809National Natural Science Foundation of China (22071066), CAMS Innovation Fund for Medical Science (CIFMS, No. 2018-12M-1-004) and the project from department of Education, Jiangsu Province for the School of CHIPS at XJTLU (EFP10120240023). Lijun Yang: Writing – original draft, Visualization, Resources, Methodology, Investigation, Formal analysis, Conceptualization. Cancan Yao: Methodology, Investigation, Data curation. Zhenning Su: Methodology, Formal analysis, Data curation. Yihao Fang: Methodology, Data curation. Nil Kanatha Pandey: Methodology, Formal analysis, Data curation. Eric Amador: Investigation, Formal analysis, Data curation. Tian Diao: Methodology, Formal analysis, Data curation. Guo Bao: Project administration, Data curation, Conceptualization. Derong Cao: Supervision, Methodology, Conceptualization. Xihua Chen: Resources, Methodology, Investigation, Data curation. Xiangbo Xu: Methodology, Funding acquisition, Formal analysis. Bin He: Supervision, Project administration, Methodology, Funding acquisition, Formal analysis, Conceptualization. Yufeng Zheng: Writing – review & editing, Supervision, Project administration, Methodology, Investigation, Funding acquisition, Conceptualization. Wei Chen: Writing – review & editing, Validation, Supervision, Project administration, Funding acquisition, Conceptualization."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025